Growth Hormone Deficiency Epidemiology Forecast and Market Analysis to 2024

1
EpiCast Report Growth Hormone Deficiency -
Epidemiology Forecast to 2024 By
RnRMarketResearch
This is a premium report price at US3995 for a
single user PDF license

• Browse more reports on Therapeutics at
• http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals/therapeutics .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
EpiCast Report Growth Hormone Deficiency -
Epidemiology Forecast to 2024

• Growth hormone deficiency (GHD) is an endocrine
  disorder characterized by low or deficient
  secretion of growth hormone (GH) secondary to
  malfunction of the pituitary gland, a pea-sized
  structure located at the base of the brain that
  is responsible for the production of GH. The
  International Classification of Diseases (ICD-10)
  ICD-10-CM code for GHD is E23.0.
• GHD in children can be classified as idiopathic
  or organic, which is further divided into
  congenital and acquired. GH is necessary for
  normal growth, as it fuels childhood growth and
  development. In an adult's normal lifespan, GH is
  needed to maintain the amounts of body fat,
  muscle, and bone necessary for sustaining tissue
  and organ function.
• Request a sample copy of this report at
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname413694 .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024
In the 7MM, the diagnosed prevalent cases of GHD
for all ages and both sexes will increase from
97,985 cases in 2014 to 100,494 cases in 2024, at
an Annual Growth Rate (AGR) of 0.26. GlobalData
epidemiologists forecast a small increase in the
AGR of the diagnosed prevalent cases of GHD from
2014-2024 for all included markets except for
Germany and Japan. The majority of diagnosed
prevalent cases of GHD in children in the 7MM are
in boys. In the 7MM, 68.05 of the GHD cases in
children are in boys and the trend is consistent
in the individual markets. In adults, the
distribution is also skewed towards men in the US
and the 5EU.
http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024

• Scope
• The GHD epidemiology report is written and
  developed by Mastersand PhD-level
  epidemiologists.
• The EpiCast Report is in-depth, high quality,
  transparent and market-driven, providing expert
  analysis of disease trends in the 7MM.
• The Growth Hormone Deficiency (GHD) EpiCast
  Report provides an overview of the risk factors
  and global trends of GHD in the 7MM (US, France,
  Germany, Italy, Spain, UK, and Japan). It
  includes a 10-year epidemiological forecast for
  the GHD diagnosed in children (18 years) and in
  adults (gt18 years) segmented by sex from
  2014-2024.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024

• Reasons to buy
• Develop business strategies by understanding the
  trends shaping and driving the global GHD market.
• Quantify patient populations in the global GHD
  market to improve product design, pricing, and
  launch plans.
• Organize sales and marketing efforts by
  identifying the age groups and sex that present
  the best opportunities for GHD therapeutics in
  each of the markets covered.
• Identify the percentage of GHD diagnosed
  prevalent cases by etiological classification.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441